Metal-Based Radiopharmaceuticals in Inorganic Chemistry

doi:10.3390/books978-3-0365-6988-8

Download Url(s)

https://mdpi.com/books/pdfview/book/6962

Contributor(s)

Boschi, Alessandra (editor)

Martini, Petra (editor)

Language

English

Show full item record

Abstract

The field of radiopharmaceuticals is constantly evolving thanks to the great contributions of specialists coming from different disciplines such as inorganic chemistry, radiochemistry, organic and biochemistry, pharmacology, nuclear medicine, physics, etc. In particular, the use of radiometals has experienced a great increase as a result of the development of radionuclides production technologies. In this particular area, inorganic chemistry skills are mainly involved in developing target-specific radiopharmaceuticals based on radiometals for non-invasive disease detection and cancer radiotherapy.The Special Issue “Metal-Based Radiopharmaceuticals in Inorganic Chemistry” includes eleven research articles and one review. The production and applications of conventional and newly emerging research radiometals for diagnosis, therapy, and theranostics are the main focus of this Special Issue.

URI

https://directory.doabooks.org/handle/20.500.12854/98909

Keywords

fusarinine C; click chemistry; fluorescence; optical imaging; PET; gallium-68; Zirconium-89; automation; radiolabelling; radioimmunotherapy; bismuth-213; invasive fungal infections; 1-3-beta-glucan; dogs; cholecystokinin-2 receptor; indium-111 labelling; nastorazepide; radiopharmaceuticals; high-resolution mass spectrometry; rhenium complexes; chemical derivatization; coordination chemistry; DFT; microfluidics; liquid–liquid extraction; technetium-99m; in-flow chemistry; dissolution system; radiopharmaceutical; solid targets; radiometals production; cyclotron production; radiochemistry; manganese-52; zirconium-89; targeted radionuclide therapy; auger emission; radionuclide production; lanthanide separation; erbium-165; 165Er; calixarenes; barium; chelation; Cu-67; copper radionuclides production; theranostics; photonuclear method; cobalt isotopes; cobalt-55; extraction chromatography; nuclear medicine; scavenger receptor B type I; reconstituted high-density lipoproteins; actinium-225; 225Ac-rHDL; targeted alpha-particle therapy; n/a